Taro Vit Industries
Executive Summary
Is correct name of multi-national pharmaceutical firm. Company's 1988 sales rose 5.2% to U.S. $9.3 mil. and net income was U.S. $119,000 compared to $11,000 in 1987. Fourth quarter sales declined 22% to U.S. $2.2 mil. due to a sudden devaluation of the Israeli shekel on Dec. 31, firm said. Taro Vit's name and sales and earnings numbers were incorrect in the April 17 edition.